Progressive cholinergic decline in Alzheimer's Disease: consideration for treatment with donepezil 23 mg in patients with moderate to severe symptomatology (Q30998627)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
Progressive cholinergic decline in Alzheimer's Disease: consideration for treatment with donepezil 23 mg in patients with moderate to severe symptomatology
scientific article

    Statements

    instance of
    review article
    8 references
    stated in
    PubMed
    retrieved
    25 April 2019
    stated in
    PubMed
    retrieved
    12 September 2019
    stated in
    PubMed
    retrieved
    17 September 2019
    stated in
    PubMed
    retrieved
    2 October 2019
    stated in
    PubMed
    retrieved
    7 November 2019
    stated in
    PubMed
    retrieved
    13 November 2019
    stated in
    PubMed
    retrieved
    30 January 2021
    stated in
    PubMed
    retrieved
    29 April 2021
    title
    Progressive cholinergic decline in Alzheimer's Disease: consideration for treatment with donepezil 23 mg in patients with moderate to severe symptomatology (English)
    1 reference
    stated in
    Europe PubMed Central
    PMC publication ID
    3042005
    retrieved
    19 October 2017
    main subject
    Alzheimer's disease
    6 references
    stated in
    PubMed
    retrieved
    25 April 2019
    stated in
    PubMed
    retrieved
    12 September 2019
    stated in
    PubMed
    retrieved
    17 September 2019
    stated in
    PubMed
    retrieved
    2 October 2019
    stated in
    PubMed
    retrieved
    7 November 2019
    stated in
    PubMed
    retrieved
    13 November 2019
    nerve degeneration
    8 references
    stated in
    PubMed
    retrieved
    25 April 2019
    stated in
    PubMed
    retrieved
    12 September 2019
    stated in
    PubMed
    retrieved
    17 September 2019
    stated in
    PubMed
    retrieved
    2 October 2019
    stated in
    PubMed
    retrieved
    7 November 2019
    stated in
    PubMed
    retrieved
    13 November 2019
    stated in
    PubMed
    retrieved
    30 January 2021
    stated in
    PubMed
    retrieved
    29 April 2021
    nervous system
    1 reference
    stated in
    PubMed
    retrieved
    12 September 2019
    heterocyclic compound
    1 reference
    stated in
    PubMed
    retrieved
    17 September 2019
    mechanism of action
    1 reference
    stated in
    PubMed
    retrieved
    2 October 2019
    amine
    1 reference
    stated in
    PubMed
    retrieved
    7 November 2019
    hydrocarbon
    1 reference
    stated in
    PubMed
    retrieved
    7 November 2019
    polycyclic compound
    1 reference
    stated in
    PubMed
    retrieved
    13 November 2019
    cholinesterase inhibitors
    1 reference
    stated in
    PubMed
    retrieved
    30 January 2021
    brain
    1 reference
    stated in
    PubMed
    retrieved
    29 April 2021
    cites work

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit
                      Retrieved from "https://www.wikidata.org/w/index.php?title=Q30998627&oldid=2195057821"